The board of the Brazilian Development Bank (BNDES) has approved R$ 250.8 million in financing for Libbs Pharmaceutical. The resources are earmarked for the construction of a pharmaceuticals plant, focused on producing biotechnological medicines to treat cancer and autoimmune diseases. It is the most dynamic segment in the pharmaceutical industry.

The Brazilian Development Bank (BNDES) has approved non-reimbursable financial support to the tune of R$ 21.9 million to develop technology to convert sugarcane biomass into ethanol. The operation, together with the National Center for Research of Energy and Materials (CNPEM), is within the scope of the BNDES-Finep’s Joint Plan to Support Industrial Technological Innovation in Sugarcane Sectors (PAISS).

The Brazilian Development Bank (BNDES) registered net earnings of R$ 8.15 billion in the 2013 fiscal year, which is similar to the previous year, when net earnings totaled R$ 8.126 billion. Last year’s results also show an improvement in other important indicators, highlighting not only the fall in default, which hit the Bank’s record low, but also the advance in allowances for credit risk.

The Brazilian Development Bank (BNDES) approved a R$ 1.8 billion bridge loan for the project to implement the Port of Açu, controlled by the company Prumo, of the EIG Group. The US group took control of the Port of Açu during the restructuring process of the EBX Group.